)
Pharmicell Co (A005690) investor relations material
Pharmicell Co Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Operates two divisions: Bio-Medical (stem cell therapies, storage, cosmetics) and Bio-Chemical (pharmaceutical intermediates, electronic materials, flame retardants).
Q1 FY2026 revenue was KRW 36.7 billion, with Bio-Chemical contributing 98% of sales.
Major R&D focus on stem cell therapies for liver cirrhosis, erectile dysfunction, and chronic kidney disease, with multiple clinical trials ongoing.
Maintains a robust patent portfolio and active government-supported research projects.
Financial highlights
Q1 FY2026 revenue: KRW 36.7 billion, up from KRW 27.0 billion in Q1 FY2025.
Operating income: KRW 13.1 billion; net income: KRW 11.7 billion for Q1 FY2026.
Cash and equivalents at period end: KRW 22.9 billion.
Total assets: KRW 168.1 billion; equity: KRW 132.8 billion.
Dividend of KRW 50 per share for FY2025, up from KRW 20 per share in FY2024.
Segment performance
Bio-Medical: Q1 FY2026 sales KRW 686 million (1.87% of total), mainly from cosmetics and cell therapy.
Bio-Chemical: Q1 FY2026 sales KRW 36.0 billion (98.13% of total), led by nucleosides, PEG derivatives, and flame retardants.
- H1 2024 saw lower sales and profit, but Bio-Chemical remains the main growth engine.A005690
Q2 202430 Jun 2026 - Q3 2024 revenue dropped 22.8% YoY to ₩43.4B, with net income at ₩2.18B.A005690
Q3 202430 Jun 2026 - 2024 revenue up 15% and net income up 77%, led by Bio-Chemical growth and margin gains.A005690
Q4 202430 Jun 2026 - Q1 2025 revenue and profit soared on Bio-Chemical strength and robust R&D pipeline.A005690
Q1 202530 Jun 2026 - Revenue and profit surged on Bio-Chemical growth, with robust cash flow and new plant investment.A005690
Q3 202530 Jun 2026 - Revenue and profit surged on Bio Chemical growth and AI material demand, with strong margins.A005690
Q4 202530 Jun 2026 - Operating and net income surged in H1 2025 despite lower revenue, led by Bio-Chemical sales.A005690
Q2 202530 Jun 2026
Next Pharmicell Co earnings date
Next Pharmicell Co earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)